Justices Expected To Write Final Chapter On Gene Patents

Law360, New York (September 25, 2012, 6:59 PM EDT) -- The American Civil Liberties Union asked the U.S. Supreme Court on Tuesday to decide whether breast cancer genes isolated by Myriad Genetics Inc. are patent-eligible subject matter, and attorneys expect the justices will take the case and seek to clarify a contentious area of the law.

The ACLU, which argues that human genes are products of nature that are not eligible for patents under Section 101 of the Patent Act, is appealing the Federal Circuit's August ruling that isolated DNA can be patented because it is...
To view the full article, register now.